Nanoscale materials and nanodevices offer new possibilities for early and accurate diagnosis of ALS. For instance, nanoparticles can be engineered to cross the blood-brain barrier and deliver diagnostic agents directly to the central nervous system. Additionally, nanosensors can detect biomarkers at extremely low concentrations, potentially allowing for earlier diagnosis and monitoring of disease progression.
